Status:
NOT_YET_RECRUITING
MOBoxy: MoblO2 to Maintain Oxygenation
Lead Sponsor:
National Jewish Health
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Stanford University
Conditions:
COPD
Interstitial Lung Disease
Eligibility:
All Genders
25+ years
Phase:
NA
Brief Summary
Many patients with chronic lung disease (e.g., chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD)) require supplemental oxygen (O2) at some point during their disease cour...
Detailed Description
This is a two-center (National Jewish Health and Stanford University), three-week, unblinded (to O2 delivery), cross-over trial of the MoblO2 device in patients with COPD or ILD who do not require O2 ...
Eligibility Criteria
Inclusion
- Previously-diagnosed COPD or chronic ILD
- Prescribed O2 for use with exertion at least 1 month prior to enrollment
- Age 25 years old or greater
- Self-reported stable symptoms and stable oxygen needs for at least 2 weeks
- Patient consent to using compressed gas tanks to deliver O2 during the 2-week study period.
Exclusion
- Active angina
- Hemoglobin less than 10mg/dL
- Musculoskeletal disease that precludes physical activity
- Ongoing participation or plans for participation in pulmonary rehabilitation during the study
- Need for O2 at rest
- Patient needing more than 10 L/min continuous flow with exertion on O2 screen. Patient prescribed 10L/min continuous flow (or more) by their prescribing physician
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT07222592
Start Date
December 1 2025
End Date
August 1 2026
Last Update
October 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305